Potential Assets in the Battle Against Multi-Drug-Resistant Bacteria: Darobactin, Nusbiarylins, Peptidomimetics, and Bacteriohages
Multi-Drug-Resistant (MDR) bacteria have presented a major public health concern for several years now. An estimated 700,000 deaths per...